RxDoctor Payments DataLook up a doctor →

Thrombate III: payments to doctors

Payments that named Thrombate III as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$245K
Providers
528
Transactions
816
Average per transaction
$300

The per-transaction average — $300 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 528 providers the average total is $463, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Grifols USA, LLC$157,88064.5%
Grifols Shared Services North America, Inc.$56,85123.2%
Grifols, S.A.$29,88112.2%
← All drugs & devices